GoldenGolden
Advanced Search
Day One Biopharmaceuticals

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a cancer Treatments.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

February 2021
Day One Biopharmaceuticals raises a $130,000,000 series B round from Access Biotechnology, Associates, Atlas Venture, BVF Partners, Boxer Capital, CANAAN, Franklin Templeton Investments, Janus Henderson Investors, Perceptive Advisors, RA Capital Management, T. Rowe Price and Viking Global Investors.
May 2020
Day One Biopharmaceuticals raises a $60,000,000 series A round from Access Biotechnology, Atlas Venture and Canaan Partners.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.